Swedish probiotic company BioGaia has signed a new supply and licence agreement with Nestlé for the inclusion of BioGaia’s patented Lactobacillus reuteri in a new category of products. The long-term agreement gives Nestlé exclusive rights to utilise this probiotic in an additional range of products in a large number of countries, with focus on emerging markets.
Lactobacillus reuteri will be added to an existing Nestlé product line. BioGaia notes that this development has been greatly facilitated by the available clinical studies it has performed and claims that it represents a great opportunity to offer a differentiated and value-added solution to consumers.
This is the third agreement BioGaia has secured with Nestlé after the company sold a perpetual licence to use Lactobacillus reuteri in infant nutrition products to Nestlé in February 2012. According to BioGaia, it illustrates the good collaboration between the two companies with cooperation in both the scientific as well as the commercial fields.
“We are very pleased to have been able to conclude this agreement with Nestlé as it gradually replaces a significant part of the business that we earlier sold to them. It reflects the excellent partnership established,” said Peter Rothschild, president, BioGaia.
